CCMNYSEServices-Offices & Clinics of Doctors of Medicine

Concord Medical Services Holdings Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026

$3.56−0.07 (-1.93%)

Close on Oct 19, 2026

Concord Medical Services Holdings Ltd income statement

Millions of CNY, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	461	384	537	472	486	223	198	191	331	455	616	607	563	456	450	390	292
Cost of Revenue	435	463	614	624	543	210	214	171	233	287	353	275	218	165	159	123	88
Gross Profit	26	-79	-77	-152	-57	13	-16	20	98	168	263	332	345	291	291	267	205
General & Administrative	213	404	330	311	348	295	315	292	238	206	133	54	85	61	81	67	30
Advertising Expenses	–	–	–	–	–	–	7.51	2.43	2.91	7.38	15	6.68	7.68	5.79	6.92	0.38	–
Operating Expenses	–	–	–	–	–	–	–	–	–	–	–	–	213	119	452	87	37
Operating Income	-261	-532	-463	-525	-458	-316	-437	-299	-212	-169	-5.74	184	156	182	-161	180	167
Interest Expense	152	193	166	120	74	81	29	46	90	89	53	53	37	12	6.45	7.45	6.89
Interest & Investment Income	9.68	14	11	10	5.89	8.44	9.17	14	12	28	22	21	9.83	5.85	13	7.87	0.95
Income from Equity Investments	13	13	21	18	18	6.02	-5.08	-21	1.45	0.62	-5.57	14	16	1.79	–	–	–
Other Non-Operating Income	-7.70	-9.26	-11	-217	-1.22	6.31	37	34	2.89	18	17	2.11	2.01	-0.31	0.35	-0.40	–
Asset Impairment Charges	0	0	0	0	0	8.50	76	5.43	29	61	23	293	0	3.36	334	3.22	–
Gain (Loss) on Investments	0	7.29	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	0.06	0.00	0	0.68	-1.30	4.71	-31	-7.62	-4.22	-3.96	-1.24	4.43	–	0.54	–
Pretax Income	-373	-670	-556	-840	529	442	391	225	254	205	-5.25	176	144	181	-165	175	161
Income Tax Expense	6.06	-18	-25	-71	-6.57	-38	-39	34	32	60	74	81	64	54	46	44	36
Income from Continuing Operations	379	652	531	769	523	404	352	-259	-286	-265	-79	95	82	129	–	–	–
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	25	11	7.59	–	–	–
Net Income incl. Noncontrolling Interests	-379	-652	-531	-769	-523	-404	-352	-259	-286	-265	-79	120	91	134	-211	131	125
Minority Interest in Earnings	-287	-344	-233	-279	-251	-94	-45	-24	-1.36	-3.22	-0.98	-4.44	5.30	3.65	3.65	1.52	–
Net Income	-93	-308	-298	-490	-271	-310	-307	-235	-284	-262	-78	125	86	131	-215	129	46
Net Income to Common	-93	-308	-298	-490	-821	-670	-553	-359	-284	-262	-78	125	86	131	-215	129	–
EPS (Basic)(per share)	-0.71	-2.35	-2.27	-3.74	-6.26	-5.11	-4.24	-2.76	-2.19	-2.00	-0.58	0.92	0.64	0.95	-1.51	0.89	0.62
EPS (Diluted)(per share)	-0.71	-2.35	-2.27	-3.74	-6.26	-5.11	-4.24	-2.76	-2.19	-2.00	-0.58	0.92	0.64	0.95	-1.51	0.89	0.62
Shares Outstanding (Basic, Weighted)(shares)	131	131	131	131	131	131	130	130	130	131	135	135	135	138	142	146	–
Shares Outstanding (Diluted, Weighted)(shares)	131	131	131	131	131	131	130	130	130	131	135	135	135	138	142	146	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 5.6%
Operating margin: -56.8%
Net margin: -20.2%
Return on equity, FY2025: 4.2%

Financial strength

Current ratio: 0.48
Debt to equity: -1.64
Debt to assets: 52.6%
Cash to current liabilities: 15.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.